Mitokinin's Incubator/Accelerator Round

Mitokinin raised a round of funding on February 02, 2018. Investors include JLabs.

Mitokinin is a biotechnology company focused on developing PINK1 targeted therapies for mitochondria-associated disorders, with particular focus on Parkinson's Disease and certain forms of mitochondri…

Articles about Mitokinin's Incubator/Accelerator Round: